Comparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell lines

dc.contributor.authorReva, Oleg N.
dc.contributor.authorRademan, Sunelle
dc.contributor.authorVisagie, M.H. (Michelle Helen)
dc.contributor.authorLebelo, Maphuti Tebogo
dc.contributor.authorGwangwa, Mokgadi Violet
dc.contributor.authorKlochko, Vitalii V.
dc.contributor.authorJoubert, Anna Margaretha
dc.contributor.authorLall, Namrita
dc.contributor.emailoleg.reva@up.ac.zaen_ZA
dc.date.accessioned2019-06-19T13:54:51Z
dc.date.available2019-06-19T13:54:51Z
dc.date.issued2019
dc.description.abstractAIM : To determine the computer-predicted anticancer activity of mupirocin and to compare its activities with those determined for another polyene antibiotic, batumin. MATERIALS AND METHODS : Molecular docking, cytotoxicity assays, cell microscopy and cell cycle progression were studied in cancer and nontumorigenic cell lines. RESULTS AND CONCLUSION : Cytotoxicity of mupirocin against several cancerous cell lines was detected with the highest one (IC50 = 5.4 μg/ml) against melanoma cell line. The profile of cytotoxicity of mupirocin was similar to that reported for batumin. Nevertheless, the morphology of cells treated with these antibiotics and alterations in cell cycle progression suggested possible dissimilarity in their mechanisms of action. Selective cytotoxicity of mupirocin against melanoma cells potentiates further studies to discover nontoxic drugs for melanoma prevention.en_ZA
dc.description.departmentBiochemistryen_ZA
dc.description.departmentGeneticsen_ZA
dc.description.departmentMicrobiology and Plant Pathologyen_ZA
dc.description.departmentPhysiologyen_ZA
dc.description.departmentPlant Production and Soil Scienceen_ZA
dc.description.librarianhj2019en_ZA
dc.description.sponsorshipAM Joubert acquired grants from the National Research Foundation (NRF; 105992, 90523 and 85818), Cancer Association of South Africa (A0V741 and A0W228), the Struwig Germeshuysen Trust (A0N074), the School of Medicine Research Committee of the University of Pretoria (AOH561) and Medical Research Council (A0W110). MH Visagie was funded from the NRF (99706), the School of Medicine Research Committee of the University of Pretoria (AOH561) and Struwig Germeshysen Trust. N Lall was funded from NRF/IKS160514165042 Grant No: 105169. ON Reva was funded from NRF grant 105996.en_ZA
dc.description.urihttps://www.future-science.com/journal/fmcen_ZA
dc.identifier.citationReva, O.N., Rademan, S., Visagie, M.H. et al. 2019, 'Comparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell lines', Future Medicinal Chemistry, vol. 11, no. 7, pp. 677-691.en_ZA
dc.identifier.issn1756-8919 (print)
dc.identifier.issn1756-8927 (online)
dc.identifier.other10.4155/fmc-2018-0333
dc.identifier.urihttp://hdl.handle.net/2263/70250
dc.language.isoenen_ZA
dc.publisherFuture Scienceen_ZA
dc.rights© 2019 Future Science Groupen_ZA
dc.subjectComputer-predicted anticancer activityen_ZA
dc.subjectMupirocinen_ZA
dc.subjectPolyene antibioticen_ZA
dc.subjectBatuminen_ZA
dc.subjectCancer cell linesen_ZA
dc.subjectNontumorigenic cell linesen_ZA
dc.subjectMolecular dockingen_ZA
dc.subjectCell cycle progressionen_ZA
dc.subjectCytotoxicity assaysen_ZA
dc.subjectCell microscopyen_ZA
dc.subjectMelanomaen_ZA
dc.subjectDrug designen_ZA
dc.subjectProphylaxisen_ZA
dc.titleComparison of structures and cytotoxicity of mupirocin and batumin against melanoma and several other cancer cell linesen_ZA
dc.typePreprint Articleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Reva_Comparison_2019.pdf
Size:
2.37 MB
Format:
Adobe Portable Document Format
Description:
Preprint Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: